{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:33:42Z","timestamp":1762004022147},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1038\/ncpneuro0494","type":"journal-article","created":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T18:58:26Z","timestamp":1178218706000},"page":"279-290","source":"Crossref","is-referenced-by-count":43,"title":["Therapy Insight: inborn errors of metabolism in adult neurology\u2014a clinical approach focused on treatable diseases"],"prefix":"10.1038","volume":"3","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Sedel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lyon-Caen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Saudubray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpneuro0494_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/35057050","volume":"409","author":"G Jimenez-Sanchez","year":"2001","unstructured":"Jimenez-Sanchez G  et al. (2001) Human disease genes. Nature 409: 853\u2013855","journal-title":"Nature"},{"key":"BFncpneuro0494_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/jnnp.69.1.5","volume":"69","author":"RG Gray","year":"2000","unstructured":"Gray RG  et al. (2000) Inborn errors of metabolism as a cause of neurological disease in adults: an approach to investigation. J Neurol Neurosurg Psychiatry 69: 5\u201312","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0494_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10545-006-0358-0","volume":"29","author":"JM Saudubray","year":"2006","unstructured":"Saudubray JM  et al. (2006) Clinical approach to treatable inborn metabolic diseases: an introduction. J Inherit Metab Dis 29: 261\u2013274","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0494_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-540-28785-8_1","volume-title":"Inborn Metabolic Diseases: Diagnosis and Treatment","author":"JM Saudubray","year":"2006","unstructured":"Saudubray JM  et al. (2006) A clinical approach to inherited metabolic disorders. In Inborn Metabolic Diseases: Diagnosis and Treatment, 3\u201348 (Eds Saudubray JM  et al.) Berlin: Springer-Verlag"},{"key":"BFncpneuro0494_CR5","first-page":"1327","volume-title":"The Metabolic and Molecular Bases of Inherited Diseases","author":"JM Saudubray","year":"2001","unstructured":"Saudubray JM and Charpentier C (2001) Clinical phenotypes: Diagnosis\/Algorithms. In The Metabolic and Molecular Bases of Inherited Diseases, edn 8, 1327\u20131407 (Eds Scriver CR  et al.) New York: McGraw Hill"},{"key":"BFncpneuro0494_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1056\/NEJM198609183151207","volume":"315","author":"EP DiMagno","year":"1986","unstructured":"DiMagno EP  et al. (1986) Ornithine transcarbamylase deficiency\u2014a cause of bizarre behavior in a man. N Engl J Med 315: 744\u2013747","journal-title":"N Engl J Med"},{"key":"BFncpneuro0494_CR7","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1056\/NEJM199006073222307","volume":"322","author":"PH Arn","year":"1990","unstructured":"Arn PH  et al. (1990) Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus: a cause of postpartum coma. N Engl J Med 322: 1652\u20131655","journal-title":"N Engl J Med"},{"key":"BFncpneuro0494_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/jnnp.69.6.813","volume":"69","author":"MD Bogdanovic","year":"2000","unstructured":"Bogdanovic MD  et al. (2000) Late onset heterozygous ornithine transcarbamylase deficiency mimicking complex partial status epilepticus. J Neurol Neurosurg Psychiatry 69: 813\u2013815","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0494_CR9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/jnnp.64.5.680","volume":"64","author":"M Oechsner","year":"1998","unstructured":"Oechsner M  et al. (1998) Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiatry 64: 680\u2013682","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 3","key":"BFncpneuro0494_CR10","first-page":"S338","volume":"22","author":"MC Nassogne","year":"2001","unstructured":"Nassogne MC  et al. (2001) Hereditary metabolic causes of stroke and pseudo-stroke in adulthood. Rev Med Interne 22 (Suppl 3): S338\u2013S346","journal-title":"Rev Med Interne"},{"key":"BFncpneuro0494_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jocn.2005.07.014","volume":"13","author":"G Eather","year":"2006","unstructured":"Eather G  et al. (2006) Carbamyl phosphate synthase deficiency: diagnosed during pregnancy in a 41-year-old. J Clin Neurosci 13: 702\u2013706","journal-title":"J Clin Neurosci"},{"key":"BFncpneuro0494_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1023\/A:1005492819527","volume":"21","author":"DM Cowley","year":"1998","unstructured":"Cowley DM  et al. (1998) Adult-onset arginase deficiency. J Inherit Metab Dis 21: 677\u2013678","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0494_CR13","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/01.AOG.0000157769.90230.24","volume":"105","author":"GM Enns","year":"2005","unstructured":"Enns GM  et al. (2005) Postpartum \u201cpsychosis\u201d in mild argininosuccinate synthetase deficiency. Obstet Gynecol 105: 1244\u20131246","journal-title":"Obstet Gynecol"},{"key":"BFncpneuro0494_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/jnnp.57.6.765","volume":"57","author":"F Pasquier","year":"1994","unstructured":"Pasquier F  et al. (1994) Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 57: 765\u2013766","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0494_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJM197503062921001","volume":"292","author":"JM Freeman","year":"1975","unstructured":"Freeman JM  et al. (1975) Folate-responsive homocystinuria and \u201cschizophrenia\u201d. A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. N Engl J Med 292: 491\u2013496","journal-title":"N Engl J Med"},{"key":"BFncpneuro0494_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1212\/WNL.44.2.344","volume":"44","author":"D Walk","year":"1994","unstructured":"Walk D  et al. (1994) Intermittent encephalopathy, reversible nerve conduction slowing, and MRI evidence of cerebral white matter disease in methylenetetrahydrofolate reductase deficiency. Neurology 44: 344\u2013347","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ajmg.1320450510","volume":"45","author":"JC Haworth","year":"1993","unstructured":"Haworth JC  et al. (1993) Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet 45: 572\u2013576","journal-title":"Am J Med Genet"},{"key":"BFncpneuro0494_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1001\/archneur.60.10.1457","volume":"60","author":"E Roze","year":"2003","unstructured":"Roze E  et al. (2003) Neuropsychiatric disturbances in presumed late-onset cobalamin C disease. Arch Neurol 60: 1457\u20131462","journal-title":"Arch Neurol"},{"key":"BFncpneuro0494_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(05)70154-9","volume":"365","author":"R Kauppinen","year":"2005","unstructured":"Kauppinen R (2005) Porphyrias. Lancet 365: 241\u2013252","journal-title":"Lancet"},{"key":"BFncpneuro0494_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jnnp.62.4.319","volume":"62","author":"HL Crimlisk","year":"1997","unstructured":"Crimlisk HL (1997) The little imitator\u2014porphyria: a neuropsychiatric disorder. J Neurol Neurosurg Psychiatry 62: 319\u2013328","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0494_CR21","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0140-6736(95)92347-0","volume":"346","author":"MR Asola","year":"1995","unstructured":"Asola MR (1995) A diver unconscious after gastroenteritis. Lancet 346: 1338","journal-title":"Lancet"},{"key":"BFncpneuro0494_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mds.10681","volume":"19","author":"DA Hall","year":"2004","unstructured":"Hall DA and Ringel SP (2004) Adult nonketotic hyperglycinemia (NKH) crisis presenting as severe chorea and encephalopathy. Mov Disord 19: 485\u2013486","journal-title":"Mov Disord"},{"key":"BFncpneuro0494_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0022-510X(84)90059-5","volume":"64","author":"IR Livingstone","year":"1984","unstructured":"Livingstone IR  et al. (1984) Familial intermittent ataxia with possible X-linked recessive inheritance: two patients with abnormal pyruvate metabolism and a response to acetazolamide. J Neurol Sci 64: 89\u201397","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0494_CR24","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s00134-003-1871-3","volume":"29","author":"F Feillet","year":"2003","unstructured":"Feillet F  et al. (2003) Adult presentation of MCAD deficiency revealed by coma and severe arrythmias. Intensive Care Med 29: 1594\u20131597","journal-title":"Intensive Care Med"},{"key":"BFncpneuro0494_CR25","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/brain\/121.7.1267","volume":"121","author":"PT Ozand","year":"1998","unstructured":"Ozand PT  et al. (1998) Biotin-responsive basal ganglia disease: a novel entity. Brain 121: 1267\u20131279","journal-title":"Brain"},{"key":"BFncpneuro0494_CR26","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1212\/01.WNL.0000144192.30426.38","volume":"63","author":"ST Pendlebury","year":"2004","unstructured":"Pendlebury ST  et al. (2004) Strokelike presentation of Wilson disease with homozygosity for a novel T766R mutation. Neurology 63: 1982\u20131983","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR27","first-page":"1","volume":"37","author":"SH Mudd","year":"1985","unstructured":"Mudd SH  et al. (1985) The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37: 1\u201331","journal-title":"Am J Hum Genet"},{"key":"BFncpneuro0494_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1212\/01.WNL.0000042479.55406.B3","volume":"60","author":"PJ Kelly","year":"2003","unstructured":"Kelly PJ  et al. (2003) Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency. Neurology 60: 275\u2013279","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/WNL.41.8.1313","volume":"41","author":"JM Visy","year":"1991","unstructured":"Visy JM  et al. (1991) Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology 41: 1313\u20131315","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ana.410400105","volume":"40","author":"P Mitsias","year":"1996","unstructured":"Mitsias P and Levine SR (1996) Cerebrovascular complications of Fabry's disease. Ann Neurol 40: 8\u201317","journal-title":"Ann Neurol"},{"key":"BFncpneuro0494_CR31","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","volume":"366","author":"A Rolfs","year":"2005","unstructured":"Rolfs A  et al. (2005) Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366: 1794\u20131796","journal-title":"Lancet"},{"key":"BFncpneuro0494_CR32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(06)70548-8","volume":"5","author":"A Fellgiebel","year":"2006","unstructured":"Fellgiebel A  et al. (2006) CNS manifestations of Fabry's disease. Lancet Neurol 5: 791\u2013795","journal-title":"Lancet Neurol"},{"key":"BFncpneuro0494_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgme.2005.07.016","volume":"86","author":"A Dinopoulos","year":"2005","unstructured":"Dinopoulos A  et al. (2005) Atypical variants of non-ketotic hyperglycinemia. Mol Genet Metab 86: 61\u201369","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0494_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1086\/431216","volume":"77","author":"WQ Zeng","year":"2005","unstructured":"Zeng WQ  et al. (2005) Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am J Hum Genet 77: 16\u201326","journal-title":"Am J Hum Genet"},{"key":"BFncpneuro0494_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11011-005-7910-8","volume":"20","author":"R Kitzberger","year":"2005","unstructured":"Kitzberger R  et al. (2005) Wilson disease. Metab Brain Dis 20: 295\u2013302","journal-title":"Metab Brain Dis"},{"key":"BFncpneuro0494_CR36","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mds.20063","volume":"19","author":"G Mellick","year":"2004","unstructured":"Mellick G  et al. (2004) Late-onset presentation of pyruvate dehydrogenase deficiency. Mov Disord 19: 727\u2013729","journal-title":"Mov Disord"},{"key":"BFncpneuro0494_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/ana.10371","volume":"52","author":"L Van Maldergem","year":"2002","unstructured":"Van Maldergem L  et al. (2002) Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 52: 750\u2013754","journal-title":"Ann Neurol"},{"key":"BFncpneuro0494_CR38","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1086\/510023","volume":"79","author":"LC Lopez","year":"2006","unstructured":"Lopez LC  et al. (2006) Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79: 1125\u20131129","journal-title":"Am J Hum Genet"},{"key":"BFncpneuro0494_CR39","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1056\/NEJMoa043160","volume":"352","author":"VT Ramaekers","year":"2005","unstructured":"Ramaekers VT  et al. (2005) Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. N Engl J Med 352: 1985\u20131991","journal-title":"N Engl J Med"},{"key":"BFncpneuro0494_CR40","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/mds.21020","volume":"21","author":"D Berg","year":"2006","unstructured":"Berg D and Hochstrasser H (2006) Iron metabolism in Parkinsonian syndromes. Mov Disord 21: 1299\u20131310","journal-title":"Mov Disord"},{"issue":"Suppl 6","key":"BFncpneuro0494_CR41","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1002\/ana.10630","volume":"54","author":"M Segawa","year":"2003","unstructured":"Segawa M  et al. (2003) Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 54 (Suppl 6): S32\u2013S45","journal-title":"Ann Neurol"},{"key":"BFncpneuro0494_CR42","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1212\/01.WNL.0000142083.47927.0A","volume":"63","author":"A Schiller","year":"2004","unstructured":"Schiller A  et al. (2004) Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Neurology 63: 1524\u20131526","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR43","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1212\/01.wnl.0000247274.21261.b4","volume":"67","author":"J Friedman","year":"2006","unstructured":"Friedman J  et al. (2006) Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency. Neurology 67: 2032\u20132035","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1212\/WNL.37.3.519","volume":"37","author":"K Tanaka","year":"1987","unstructured":"Tanaka K  et al. (1987) Dihydrobiopterin synthesis defect: an adult with diurnal fluctuation of symptoms. Neurology 37: 519\u2013522","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR45","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2788.1997.tb00699.x","volume":"41","author":"D Pogson","year":"1997","unstructured":"Pogson D (1997) Issues for consideration in dihydropteridine reductase (DHPR) deficiency: a variant form of hyperphenylalaninaemia. J Intellect Disabil Res 41: 208\u2013214","journal-title":"J Intellect Disabil Res"},{"key":"BFncpneuro0494_CR46","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1212\/01.wnl.0000249335.35585.3e","volume":"67","author":"F Sedel","year":"2006","unstructured":"Sedel F  et al. (2006) Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia. Neurology 67: 2243\u20132245","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR47","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/jnnp.51.6.859","volume":"51","author":"PA Kempster","year":"1988","unstructured":"Kempster PA  et al. (1988) Dystonia in homocystinuria. J Neurol Neurosurg Psychiatry 51: 859\u2013862","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0494_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N  et al. (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 79: 104\u2013109","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0494_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0960-8966(00)00112-7","volume":"10","author":"A Verrips","year":"2000","unstructured":"Verrips A  et al. (2000) Cerebrotendinous xanthomatosis: controversies about nerve and muscle: observations in ten patients. Neuromuscul Disord 10: 407\u2013414","journal-title":"Neuromuscul Disord"},{"key":"BFncpneuro0494_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archneur.1980.00500590083015","volume":"37","author":"DR Illingworth","year":"1980","unstructured":"Illingworth DR  et al. (1980) Abetalipoproteinemia: report of two cases and review of therapy. Arch Neurol 37: 659\u2013662","journal-title":"Arch Neurol"},{"key":"BFncpneuro0494_CR51","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1001\/archneur.62.10.1628","volume":"62","author":"KH Jung","year":"2005","unstructured":"Jung KH  et al. (2005) Wilson disease with an initial manifestation of polyneuropathy. Arch Neurol 62: 1628\u20131631","journal-title":"Arch Neurol"},{"key":"BFncpneuro0494_CR52","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0022-3476(98)70464-0","volume":"132","author":"B Wolf","year":"1998","unstructured":"Wolf B  et al. (1998) Delayed-onset profound biotinidase deficiency. J Pediatr 132: 362\u2013365","journal-title":"J Pediatr"},{"key":"BFncpneuro0494_CR53","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJM199002153220704","volume":"322","author":"G Mitchell","year":"1990","unstructured":"Mitchell G  et al. (1990) Neurologic crises in hereditary tyrosinemia. N Engl J Med 322: 432\u2013437","journal-title":"N Engl J Med"},{"key":"BFncpneuro0494_CR54","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00431-006-0104-5","volume":"165","author":"FG Debray","year":"2006","unstructured":"Debray FG  et al. (2006) Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency. Eur J Pediatr 165: 462\u2013466","journal-title":"Eur J Pediatr"},{"key":"BFncpneuro0494_CR55","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/qjmed\/94.8.403","volume":"94","author":"AJ Wills","year":"2001","unstructured":"Wills AJ  et al. (2001) Refsum's disease. QJM 94: 403\u2013406","journal-title":"QJM"},{"key":"BFncpneuro0494_CR56","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1172\/JCI2091","volume":"102","author":"JA Ibdah","year":"1998","unstructured":"Ibdah JA  et al. (1998) Mild trifunctional protein deficiency is associated with progressive neuropathy and myopathy and suggests a novel genotype\u2013phenotype correlation. J Clin Invest 102: 1193\u20131199","journal-title":"J Clin Invest"},{"key":"BFncpneuro0494_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2007-973447","volume":"30","author":"TJ De Koning","year":"1999","unstructured":"De Koning TJ  et al. (1999) Continuing education in neurometabolic disorders\u2014serine deficiency disorders. Neuropediatrics 30: 1\u20134","journal-title":"Neuropediatrics"},{"key":"BFncpneuro0494_CR58","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/ana.410440505","volume":"44","author":"MR Baumgartner","year":"1998","unstructured":"Baumgartner MR  et al. (1998) Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol 44: 720\u2013730","journal-title":"Ann Neurol"},{"key":"BFncpneuro0494_CR59","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/72861","volume":"24","author":"S Ferdinandusse","year":"2000","unstructured":"Ferdinandusse S  et al. (2000) Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet 24: 188\u2013191","journal-title":"Nat Genet"},{"key":"BFncpneuro0494_CR60","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ana.78","volume":"49","author":"JM Powers","year":"2001","unstructured":"Powers JM  et al. (2001) Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. Ann Neurol 49: 396\u2013400","journal-title":"Ann Neurol"},{"key":"BFncpneuro0494_CR61","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1212\/WNL.57.5.911","volume":"57","author":"FM Salvi","year":"2001","unstructured":"Salvi FM  et al. (2001) Clinical and molecular findings in hyperornithinemia\u2013hyperammonemia\u2013homocitrullinuria syndrome. Neurology 57: 911\u2013914","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR62","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp.71.6.795","volume":"71","author":"S Kasim","year":"2001","unstructured":"Kasim S  et al. (2001) Phenylketonuria presenting in adulthood as progressive spastic paraparesis with dementia. J Neurol Neurosurg Psychiatry 71: 795\u2013797","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0494_CR63","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/jnnp.55.5.359","volume":"55","author":"PA McCombe","year":"1992","unstructured":"McCombe PA  et al. (1992) Spasticity and white matter abnormalities in adult phenylketonuria. J Neurol Neurosurg Psychiatry 55: 359\u2013361","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0494_CR64","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ymgme.2004.12.001","volume":"84","author":"FJ Hansen","year":"2005","unstructured":"Hansen FJ and Blau N (2005) Cerebral folate deficiency: life-changing supplementation with folinic acid. Mol Genet Metab 84: 371\u2013373","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0494_CR65","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/brain\/122.8.1589","volume":"122","author":"A Verrips","year":"1999","unstructured":"Verrips A  et al. (1999) Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain 122: 1589\u20131595","journal-title":"Brain"},{"key":"BFncpneuro0494_CR66","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1023\/A:1005334712056","volume":"20","author":"A Tokatli","year":"1997","unstructured":"Tokatli A  et al. (1997) Biotinidase deficiency with neurological features resembling multiple sclerosis. J Inherit Metab Dis 20: 707\u2013708","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0494_CR67","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/adc.73.3.256","volume":"73","author":"K Patel","year":"1995","unstructured":"Patel K  et al. (1995) Dopa responsive dystonia. Arch Dis Child 73: 256\u2013257","journal-title":"Arch Dis Child"},{"key":"BFncpneuro0494_CR68","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1212\/WNL.56.2.260","volume":"56","author":"Y Furukawa","year":"2001","unstructured":"Furukawa Y  et al. (2001) Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology 56: 260\u2013263","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR69","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0022-510X(98)00038-0","volume":"156","author":"F Martinello","year":"1998","unstructured":"Martinello F  et al. (1998) Supplemental therapy in isolated vitamin E deficiency improves the peripheral neuropathy and prevents the progression of ataxia. J Neurol Sci 156: 177\u2013179","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0494_CR70","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.20531","volume":"58","author":"VM Homer","year":"2005","unstructured":"Homer VM  et al. (2005) Mental retardation and ataxia due to normotriglyceridemic hypobetalipoproteinemia. Ann Neurol 58: 160\u2013163","journal-title":"Ann Neurol"},{"key":"BFncpneuro0494_CR71","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/brain\/123.5.908","volume":"123","author":"A Verrips","year":"2000","unstructured":"Verrips A  et al. (2000) Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 123: 908\u2013919","journal-title":"Brain"},{"key":"BFncpneuro0494_CR72","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1212\/01.WNL.0000055089.39373.FC","volume":"60","author":"C Lamperti","year":"2003","unstructured":"Lamperti C  et al. (2003) Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60: 1206\u20131208","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR73","first-page":"119","volume":"43","author":"S Bressman","year":"1986","unstructured":"Bressman S  et al. (1986) Biotin-responsive encephalopathy with myoclonus, ataxia, and seizures. Adv Neurol 43: 119\u2013125","journal-title":"Adv Neurol"},{"key":"BFncpneuro0494_CR74","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/08830738020170111707","volume":"17","author":"MM Ryan","year":"2002","unstructured":"Ryan MM  et al. (2002) Homocystinuria presenting as psychosis in an adolescent. J Child Neurol 17: 859\u2013860","journal-title":"J Child Neurol"},{"key":"BFncpneuro0494_CR75","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1176\/jnp.3.4.377","volume":"3","author":"M Akil","year":"1991","unstructured":"Akil M  et al. (1991) The psychiatric presentations of Wilson's disease. J Neuropsychiatry Clin Neurosci 3: 377\u2013382","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"BFncpneuro0494_CR76","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1176\/ajp.145.3.354","volume":"145","author":"VM Berginer","year":"1988","unstructured":"Berginer VM  et al. (1988) Psychiatric disorders in patients with cerebrotendinous xanthomatosis. Am J Psychiatry 145: 354\u2013357","journal-title":"Am J Psychiatry"},{"key":"BFncpneuro0494_CR77","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/ajmg.1320260427","volume":"26","author":"MH Abbott","year":"1987","unstructured":"Abbott MH  et al. (1987) Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness. Am J Med Genet 26: 959\u2013969","journal-title":"Am J Med Genet"},{"key":"BFncpneuro0494_CR78","first-page":"637","volume":"159","author":"JC Turpin","year":"2003","unstructured":"Turpin JC and Baumann N (2003) Presenting psychiatric and cognitive disorders in adult neurolipidoses. Rev Neurol (Paris) 159: 637\u2013647","journal-title":"Rev Neurol (Paris)"},{"key":"BFncpneuro0494_CR79","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/ana.1222","volume":"50","author":"K Brockmann","year":"2001","unstructured":"Brockmann K  et al. (2001) Autosomal dominant glut-1 deficiency syndrome and familial epilepsy. Ann Neurol 50: 476\u2013485","journal-title":"Ann Neurol"},{"key":"BFncpneuro0494_CR80","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/hmg\/10.1.63","volume":"10","author":"J Klepper","year":"2001","unstructured":"Klepper J  et al. (2001) Autosomal dominant transmission of GLUT1 deficiency. Hum Mol Genet 10: 63\u201368","journal-title":"Hum Mol Genet"},{"key":"BFncpneuro0494_CR81","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1212\/WNL.33.8.994","volume":"33","author":"MD Winkelman","year":"1983","unstructured":"Winkelman MD  et al. (1983) Non-infantile neuronopathic Gaucher's disease: a clinicopathologic study. Neurology 33: 994\u20131008","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR82","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/jnnp.2003.033951","volume":"76","author":"AS Winkler","year":"2005","unstructured":"Winkler AS  et al. (2005) Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases. J Neurol Neurosurg Psychiatry 76: 380\u2013383","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0494_CR83","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/brain\/111.5.1139","volume":"111","author":"TR Dening","year":"1988","unstructured":"Dening TR  et al. (1988) Wilson's disease and epilepsy. Brain 111: 1139\u20131155","journal-title":"Brain"},{"key":"BFncpneuro0494_CR84","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1528-1157.1991.tb04705.x","volume":"32","author":"A Arlazoroff","year":"1991","unstructured":"Arlazoroff A  et al. (1991) Epileptic seizure as a presenting symptom of cerebrotendinous xanthomatosis. Epilepsia 32: 657\u2013661","journal-title":"Epilepsia"},{"key":"BFncpneuro0494_CR85","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10545-005-0243-2","volume":"29","author":"PT Clayton","year":"2006","unstructured":"Clayton PT (2006) B6-responsive disorders: a model of vitamin dependency. J Inherit Metab Dis 29: 317\u2013326","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0494_CR86","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJM200108093450606","volume":"345","author":"CM Filley","year":"2001","unstructured":"Filley CM and Kleinschmidt-DeMasters BK (2001) Toxic leukoencephalopathy. N Engl J Med 345: 425\u2013432","journal-title":"N Engl J Med"},{"key":"BFncpneuro0494_CR87","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1148\/radiology.217.3.r00dc03869","volume":"217","author":"F Barkhof","year":"2000","unstructured":"Barkhof F  et al. (2000) Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 217: 869\u2013876","journal-title":"Radiology"},{"key":"BFncpneuro0494_CR88","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1212\/01.WNL.0000158476.74580.A8","volume":"64","author":"AL Boxer","year":"2005","unstructured":"Boxer AL  et al. (2005) Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. Neurology 64: 1431\u20131434","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR89","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1212\/01.WNL.0000036616.11962.3C","volume":"59","author":"O Bahr","year":"2002","unstructured":"Bahr O  et al. (2002) Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology 59: 1802\u20131804","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR90","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1212\/01.WNL.0000167428.12417.B2","volume":"64","author":"S Kulkens","year":"2005","unstructured":"Kulkens S  et al. (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64: 2142\u20132144.","journal-title":"Neurology"},{"key":"BFncpneuro0494_CR91","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/brain\/116.4.811","volume":"116","author":"AJ Thompson","year":"1993","unstructured":"Thompson AJ  et al. (1993) Brain MRI changes in phenylketonuria: associations with dietary status. Brain 116: 811\u2013821.","journal-title":"Brain"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0494","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0494.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:26:31Z","timestamp":1650101191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["BFncpneuro0494"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0494","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}